Sigilon Therapeutics, Inc.
SGTXDelisted Aug 11, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821323
Sigilon Therapeutics, Inc. was delisted on Aug 11, 2023; its insiders filed their last Form 4 on Aug 15, 2023; 16 institutions reported holding it in 13F filings for Q2 2023, worth $26.6M in total; no superinvestor held it.
Holders of 5% or more of SGTX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Sigilon Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Sigilon Therapeutics, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Sigilon Therapeutics, Inc., newest first.
No Schedule 13D or 13G filings on Sigilon Therapeutics, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Sigilon Therapeutics, Inc. shares.
No Form 144 notices for Sigilon Therapeutics, Inc. are on file.